Kaprishi Pharma Private Limited

Kaprishi Pharma Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
CIN U52602AS2018PTC018600 Incorporated 29 June 2018 ROC Guwahati HQ Guwahati, Assam, India
Active Private Limited Company pharma Startup India MSME · Small
Data last updated
Revenue · FY 2023
₹1.33 Cr
▼ 77% YoY
Net profit · FY 2023
₹2.91 Lakh
Net margin 2.2%
EBITDA · FY 2023
₹16.9 Lakh
EBITDA margin 12.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Kaprishi Pharma Private Limited

Data last updated:

Kaprishi Pharma Private Limited is a private limited company based in Guwahati, Assam, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U52602AS2018PTC018600. Its GSTIN is 18AAHCK1775C1ZK (Assam).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pritikongkana Barman and Simanta Barman.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Mani Barman House No 66 Kahilipara Near Manobikash Kendra Dakshin Gaon, Guwahati, Assam, India – 781019.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.33 Cr, a decline of 77% compared to the previous year. For the same year it recorded a net profit of ₹2.91 Lakh (net margin 2.2%) and EBITDA of ₹16.9 Lakh (EBITDA margin 12.7%).

As per MCA filings, the company has open charges of ₹2 Cr on record.

Kaprishi Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-03-0006198).

Company details

CIN U52602AS2018PTC018600
Registration Number 018600
Incorporation Date 29 June 2018
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-AS-03-0006198

Recognitions & Rankings of Kaprishi Pharma

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-AS-03-0006198

Contact details

Kaprishi Pharma Private Limited's registered office is in Guwahati, Assam. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C/O Mani Barman House No 66 Kahilipara Near Manobikash Kendra Dakshin Gaon, Guwahati, Assam, India – 781019
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Kaprishi Pharma Private Limited, buy the company report.

Comprehensive company report
Kaprishi Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Kaprishi Pharma is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Kaprishi Pharma Private Limited, buy the company report.

Financials of Kaprishi Pharma Private Limited

FY 2023 filings available

Kaprishi Pharma Private Limited reported revenue of ₹1.33 Cr (down 77% YoY) for FY 2023.

Revenue · FY 2023
₹1.33 Cr ▼ 77%
Net profit · FY 2023
₹2.91 Lakh margin 2.2%
EBITDA · FY 2023
₹16.9 Lakh margin 12.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 77%
EBITDA CAGR growth
1 year
▼ 34%

Revenue fell 77% in the latest year. EBITDA fell 34% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.33 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.9 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.91 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin12.7%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Kaprishi Pharma Private Limited, buy the company report.

Board of directors of Kaprishi Pharma Private Limited

Kaprishi Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Pritikongkana BarmanDirector29 Jun 20188 Years 4 MonthsCurrent
Simanta BarmanDirector29 Jun 20188 Years 4 MonthsCurrent

Auditor

Kaprishi Pharma Private Limited is audited by BIPUL SHARMA & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
BIPUL SHARMA & ASSOCIATESFY 2023327831E

Shareholding

The shareholding of Kaprishi Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Kaprishi Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹1.60 Cr
Others₹0.40 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Oct 2023100817780State Bank of India₹1.6 CrOpen
07 Oct 2023100792399Others₹40 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Kaprishi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Kaprishi Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
18AAHCK1775C1ZKAssamActive02 Aug 2018

To see the full GST registrations and return filing status of Kaprishi Pharma Private Limited, buy the company report.

Recent activity

Kaprishi Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pritikongkana Barman was appointed as Director on 29 Jun 2018.

Charges
A charge with State Bank Of India amounted to Rs. 160.00 Lakh with Charge ID 100817780 was registered on 30 Oct 2023.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100792399 was registered on 07 Oct 2023.
AGM
Kaprishi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Kaprishi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Guwahati.
Appointed
Pritikongkana Barman was appointed as Director.
Appointed
Simanta Barman was appointed as Director.
Incorporation
29 Jun 2018
Kaprishi Pharma Private Limited was registered on 29 Jun 2018 with Roc Guwahati & aged 8 years 4 months as per MCA records.

Frequently asked questions

Kaprishi Pharma is an active private limited company based in Guwahati, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2018 (8+ years old) and is registered under CIN U52602AS2018PTC018600.

Kaprishi Pharma has 2 current directors:

The latest financial statements of Kaprishi Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Kaprishi Pharma is 18AAHCK1775C1ZK, registered in Assam.

The CIN (Corporate Identification Number) of Kaprishi Pharma is U52602AS2018PTC018600. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kaprishi Pharma was incorporated on 29 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Guwahati.

Pritikongkana Barman was appointed as Director on 29 Jun 2018. Simanta Barman was appointed as Director on 29 Jun 2018.

Yes, Kaprishi Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Kaprishi Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-AS-03-0006198).

The registered office of Kaprishi Pharma is at CO Mani Barman House No 66 Kahilipara Near Manobikash Kendra Dakshin Gaon, Guwahati, Assam, India – 781019.